Direction Centrale Du Service De Sante Des Armees — Clinical Trial Site

33 Registered trials

10 Currently recruiting

Organisation

Direction Centrale Du Service De Sante Des Armees

Location

Saint-Mande, France

Identifier

ORG-100013682

Address

Rue Colonel Fonferrier, 29200, France

Departments

#40246: Service de dermatologie
2302: Respiratory
94160
Département Respiratoire
Dermatology
Dermatology Department
HEMATOLOGIE
Médecine interne
Medical Oncology
N/A
Neurologie
Oncologie médicale
ONCOLOGY
Oncology / clinical research Unit
Oncology- pulmonology department
Pneumologie
Pneumology
Pulmonology service
Rheumatology
Service d'Oncologie
Service d'oncologie medicale
Service d’anesthésie Réanimation
Service de médecine interne
Service de pneumologie
Unité de Recherche Clinique

Clinical trials at this site (33)

Search interface

A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe … Ended

2024-511363-28-00 hidradenitis suppurativa (HS) 5 2024-09-24
A phase 3b, interventional, adaptive, clinical trial to evaluate the efficacy and safety of tralokinumab 300 mg every second week monotherap… Ended

2022-502653-34-01 Atopic dermatitis and moderate-to severe atopic hand ec 11 2024-05-30
Proof-of-concept study evaluating subcutaneous amlitelimab in adult participants with moderate to severe hidradenitis suppurativa. Ended

2023-505803-22-00 Hidradenitis 4 2024-04-15
A study to test the efficacy and safety of SAR442970 in adults with hidradenitis suppurativa Ended

2022-502370-17-00 Hidradenitis suppurativa 4 2023-11-14
A Study of Two Dose Levels of Vobramitamab Duocarmazine in Participants with Metastatic Castration-resistant Prostate Cancer (TAMARACK) Ended

2022-501078-20-00 Metastatic Castration-resistant Prostate Cancer 4 2023-05-15
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran… Ended

2023-503793-20-00 Prevention of ischemic stroke in patients post acute no 5 2023-01-18
An extension study to learn if Bimekizumab is safe and works as a long-term therapy in adults with moderate to severe hidradenitis suppurati… Ended

2024-511035-10-00 Hidradenitis Suppurativa 5 2021-06-23
MK-7684A (new drug co-formulation of pembrolizumab with an anti-TIGIT) plus docetaxel works to help stop or slow down the growth of your non… Ended

2022-501252-28-00 Non Small Cell Lung cancer 4 2021-04-15
A clinical study evaluating efficacy and safety of inupadenant in combination with carboplatin and pemetrexed in adults with metastatic nons… Ended

2024-515393-27-00 Nonsquamous non-small cell lung cancer 4